Pharma Journalist -

Theravance Biopharma and Mylan announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for revefenacin (TD-4208), an investigational…
Read More...

Allergan plc announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for VRAYLAR™ (cariprazine) for the maintenance…
Read More...

Absorption Systems announces the acquisition of TGA Sciences, Inc., a contract R&D laboratory located in Medford, MA, just outside the pharma/biotech hub of Cambridge. TGA Sciences,…
Read More...

Excision BioTherapeutics, a life science company focused on the development and commercialization of advanced gene editing therapeutics for the treatment of life-threatening disease…
Read More...

Avista Pharma Solutions, Inc. has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, Colorado site. During this expansion, the…
Read More...

Zymeworks announced that it has executed a licensing agreement with Janssen Biotech. The deal was facilitated by Johnson & Johnson Innovation. Under the terms of the licensing…
Read More...

A spotlight on patient needs in parenteral drug delivery SMi Group will focus on patient needs in parenteral drug delivery in an exclusive spotlight at the 10th annual Pre-Filled…
Read More...

Technology encapsulates our everyday lives, nowhere is this more obvious than in healthcare, where technology goes beyond convenience, it is helping to save lives. At MEDICAL FAIR ASIA…
Read More...

Social Media in the Pharmaceutical Industry conference will be bringing a global presence from GSK, Pfizer, IBM, Janssen, Roche Diabetes Care, Bristol-Myers Squibb, MSD, ABPI, and more.…
Read More...

SMi are delighted to have, Nagy Habib, Head of HPB Surgery, Imperial College London and Co-Founder, MiNA Therapeutics, as the Keynote Address for day 1 at RNA Therapeutics 2018!…
Read More...